Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion A Salvador

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Briefings in Functional Genomics|March 10, 2016
Breast cancer stem cells programs: enter the (non)-codeMarion A Salvador, Daniel Birnbaum, Emmanuelle Charafe-Jauffret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expressionMarion A Salvador, Julien Wicinski, Olivier Cabaud, et al.
Cell|May 21, 2022
XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivationLaia Richart, Mary-Loup Picod-Chedotel, Michel Wassef, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Briefings in Functional Genomics|March 10, 2016
Breast cancer stem cells programs: enter the (non)-codeMarion A Salvador, Daniel Birnbaum, Emmanuelle Charafe-Jauffret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expressionMarion A Salvador, Julien Wicinski, Olivier Cabaud, et al.
Cell|May 21, 2022
XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivationLaia Richart, Mary-Loup Picod-Chedotel, Michel Wassef, et al.
Pageof 1